Deutsch - Español - Pусско - 汉语 - Nederlands - Français - ελληνικά - Italiano - 本語 - 한국어 - Português - Svenska - Norsk - Polska - Arabic - Hindi Brain
Research and Information Network (B.R.A.I.N.) Informational
Resources on Brain Nutrition, Neuroethics, Brain Medicine, Neurobiological
Pharmaceuticals, Neuroscience, Consciousness and Cognitive Enhancement Feedback Introduction
to the Brain Brain
Facts: A Primer on the Brain and Nervous System
presented by the Society for
Neuroscience pdf Brain Nutrition Dietary
Supplements: What Do You Know? What Should You Know? The
Council for Responsible Nutrition The Science Behind
the Supplements Neuroscience
for Kids - Nutrition and the Brain an excellent introductory
orientation on how diet and nutrition effects the brain. Vitamin
E Reduces Mental Decline Among Older Persons Antioxidants
improve cognition in elderly women Can
nutrient supplements modify brain function? High-dose
antioxidant supplements and cognitive function in community-dwelling
elderly women Prenatal
Choline Supplements Make Brain Cells Larger, Faster Alcohol
and the Brain: Neuroscience and Neurobehavior a special
report on the effects of alcohol on the brain Effects of a 14-Day Healthy Longevity Lifestyle Program on Cognition and Brain Function You (and Your Brain) are What You Eat by Andrew Weil, M.D Rise in mental illness linked to unhealthy diets, say studies by Felicity Lawrence NIH Seeks Strategies to Preserve Brain Health Cognitive Health by Elizabeth Srejic Effects of nutrition on brain development in humans by G Robert Delong, Division of Pediatric Neurology, Duke University Medical Center The Healthy Brain Initiative: A National Public Health Road Map to Maintaining Cognitive Health presented by the CDC and Alzheimer's Association Mental Health Mental Health: A Report of the Surgeon General a superb report on the current state of brain and mental health Mental health a concern for older people by Bill Mead May is Mental Health Month, 'Mind Your Health' by Liz Atwell Long-term Effects of Cognitive Training on Everyday Functional Outcomes in Older Adults The Journal of the American Medical Association (JAMA) Neuroscience Research Milestones in Neuroscience Research by E.H. Chudler UCSF Research Pinpoints Brain Molecule’s Role in Developing Addiction Immune cells help maintain brain cell renewal by Judy Siegel-Itzkovich Brain Study Examines Maturation Process by Autistic brain never 'rests' by Megan Rauscher Evolution
of the Brain and Consciousness Without Miracles: Brain Evolution and Development Evolution
of Consciousness Literature Review, Notes and Excerpts
The
Evolution of Primate Intelligence Neuroethics
and Cognitive Enhancement Policy Implications of Technologies for Cognitive Enhancement The University of Arizona Neuroethics Website at The University of Pennsylvania neuroethics.upenn.edu Meeting
Neuroethical Challenges in Cognitive Enhancement a
recent conference on the ethical and social implications of cognitive
enhancement. Neuroethics:
Mapping the Field Conference proceedings. Hosted
by Stanford University and the University of California, San Francisco,
May 13-14, 2002. Articles on Brain Function, Supplementation, and Enhancement New
Research Finds that the Common Arguments Against the Development of
Cognitive Enhancers are Misguided Nov
14, 2005 The
Battle for Your Brain Science is developing ways
to boost intelligence, expand memory, and more. But will you be allowed
to change your own mind? Cognitive
Enhancers May 14, 1998 Race
Is On for a Pill to Save the Memory New York Times,
July 29, 2003 Brain
Gain: Drugs that Boost Intelligence by Julie Erlich Enhancing
Cognitive Function Keeping your memory in tip top
shape For
Fear of a 'Cognitive Divide' Developing safe, specific,
powerful memory-improving drugs raises many ethical issues about the
implications of cognitive enhancement. Supercharging
the Brain New drugs promise to improve memory and
sharpen mental response. Who should be allowed to take them? Seeking
Smart Drugs Federal and biotech labs research a new generation
of drug therapy that improves memory and concentration without side
effects 'Smart
pills' make headway Cognitive Enhancers: The New Frontier in Treating Age and Dementia No 10 scientist urges brain pills for all by David Cracknell and Steven Swinford Brain Screensavers The Secret Life of the Brain Screensaver by pbs.org (also available in Macintosh format) Wikipedia Entries Brain introductory article on brain structure, fields of study, and neurobiology
Neuroscience situates the discipline of neuroscience among related scientific research areas, delineates the history of the field, and lists major themes of research
Nootropics explores the different classes of nootropic substances (cholinergics, dopaminergics, and serotonergics) and their uses for depression, brain energy, concentration and memory enhancement
Groups and Usenet Alzheimer's Disease Support Group Mind-L neurotech Forums BrainMeta sponsored by CerebralHealth.com Neurotechnology Software Advanced Neuroscience National
Institutes of Health Seminar Series in Neuroscience online
videos in neuroscience. BrainMaps.org
a high-resolution digital brain atlas based on scanned images
of serial sections of monkey brains that is fully integrated with
a high-speed database server for querying and retrieving data about
primate brain structure and function over the internet. Brain Conditions and Disorders Research Alzheimer's Disease Brain Scans May Predict Alzheimer's Risk Can You Prevent Alzheimer's Disease? by Christine Gorman Cognitive enhancement therapy for Alzheimer's disease. The way forward Study hopes to identify brain changes in memory loss Multiple Sclerosis Vitamin D: a natural inhibitor of multiple sclerosis Schizophrenia Cognitive Enhancement Therapy for Schizophrenia: Effects of a 2-Year Randomized Trial on Cognition and Behavior Neurotransmitter Information and Research Neurotransmitters and Neuroactive Peptides an introductory presentation on neurotransmitters Brain Neurotransmitters by Ben Best Acetylcholine Acetlycholine a solid introduction to acetylcholine by Dr. William S. Messer, Jr., Professor of Medicinal and Biological Chemistry at The University of Toledo Dopamine Dopamine Wikipedia article Serotonin Serotonin and Its Uses by Andrea Byrd Serotonin: The Neurotransmitter for the 90's by Ronald F. Borne, Ph.D., Department of Medicinal Chemistry, School of Pharmacy, University of Mississippi Histamine Histamine by Dr. William S. Messer, Jr., Professor of Medicinal and Biological Chemistry at The University of Toledo Norepinephrine Norepinephrine in Psychiatry by John J. Spollen III, MD Norepinephrine by Gary Aston-Jones Epinephrine Epinephrine Wikipedia entry Cognitive Enhancers
Research Abstracts Acetyl-L-carnitine Acetyl-L-carnitine
for dementia. A
1-year controlled trial of acetyl-l-carnitine in early-onset AD. Feeding
acetyl-L-carnitine and lipoic acid to old rats significantly improves
metabolic function while decreasing oxidative stress. Comparison
of the effects of acetyl l-carnitine and amantadine for the treatment
of fatigue in multiple sclerosis: results of a pilot, randomised,
double-blind, crossover trial Effects
of acetyl-L-carnitine in Alzheimer's disease patients unresponsive
to acetylcholinesterase inhibitors Alpha GPC Cognition stimulating drugs modulate protein kinase C activity in cerebral cortex and hippocampus of … Multicentre study of l-alpha-glyceryl-phosphorylcholine vs ST200 among patients with probable senile … Effects of L-alpha-glycerylphosphorylcholine on the EEG power spectrum in the rat Chronic L-alpha-glyceryl-phosphoryl-choline increases inositol phosphate formation in brain slices … alpha-Glycerophosphocholine in the mental recovery of cerebral ischemic attacks. An Italian … Aniracetam Nootropic
Agents Enhance the Recruitment of Fast GABAA Inhibition in Rat Neocortex
The
Mechanism of Action of Aniracetam at Synaptic -Amino-3-hydroxy-5-methyl-4-isoxazolepropionic
Acid (AMPA) Receptors: Indirect and Direct Effects on Desensitization Allosteric potentiation of quisqualate receptors by a nootropic drug aniracetam AIT-082 Neotrofin, leteprinim potassium AIT-082,
a Cognitive Enhancer, Is Transported into Brain by a Nonsaturable
Influx Mechanism and out of Brain by a Saturable Efflux Mechanism Ashwagandha Scientific Basis for the Therapeutic Use of Withania Somnifera (Ashwagandha): A Review Studies on the immunomodulatory effects of Ashwagandha Dendrite extension by methanol extract of Ashwagandha (roots of Withania somnifera) in SK-N-SH cells Axon- or dendrite-predominant outgrowth induced by constituents from Ashwagandha Centrophenoxine Modulatory effects of centrophenoxine on different regions of ageing rat brain Study of the effect of centrophenoxine on experimental animals poisoned with chlordiazepoxide Age-related decline in multiple unit action potentials of CA3 region of rat hippocampus: correlation with lipid peroxidation and lipofuscin concentration and the effect of centrophenoxine. Effect of centrophenoxine on the lipofuscin pigments in the neurones of senile guinea-pigs. Choline Choline: A Vital Amine Choline and Human Nutrition Choline: an essential nutrient for humans Choline: an important nutrient in brain development, liver function and carcinogenesis Docosahexaenoic
Acid (DHA) Health
Benefits of Docosahexaenoic Acid (DHA) Visual
acuity and the essentiality of docosahexaenoic acid and arachidonic
acid in the diet of term infants Decrease
in neuron size in docosahexaenoic acid-deficient brain. Therapeutic
effects of docosahexaenoic acid ethyl ester in patients with generalized
peroxisomal disorders. Efficacy
and Safety of Docosahexaenoic Acid and Arachidonic Acid Addition to
Infant Formulas: Can One Buy Better Vision and Intelligence? Modification
by docosahexaenoic acid of age-induced alterations in gene expression
and molecular composition of rat brain phospholipids General Treatment,
enhancement, and the ethics of neurotherapeutics Histone
Deacetylase Inhibitors as Cognitive Enhancers An hypothesis on the role of glucose in the mechanism of action of cognitive enhancers Cognitive enhancers in theory and practice: studies of the cholinergic hypothesis of cognitive … Effects of four non-cholinergic cognitive enhancers in comparison with tacrine and galanthamine on … … flow abolished by scopolamine is reversed by cognitive enhancers associated with cholinesterase … Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to … Cognitive enhancers and hippocampal long-term potentiation in vitro AMPA receptor modulators as cognitive enhancers … brain of the senescence-accelerated mouse: an animal model useful for studies on cognitive enhancers CREB and the discovery of cognitive enhancers Applications software as cognitive enhancers Ginkgo
Biloba Ginkgo
for memory enhancement: a randomized controlled trial. Neuroprotective
effects of Ginkgo biloba extract Huperzine-A Structure of acetylcholinesterase complexed with the nootropic alkaloid, (−)-huperzine A Efficacy of tablet huperzine-A on memory, cognition, and behavior in Alzheimer's disease. Hydergine The
effects of an ergot alkaloid derivative (Hydergine) on aspects of
psychomotor performance, arousal, and cognitive processing ability
Idebenone Sustained efficacy and safety of idebenone in the treatment of Alzheimer’s disease: update on a 2- … A controlled study of 2 doses of idebenone in the treatment of Alzheimer’s disease Idebenone in patients with Friedreich ataxia Idebenone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in … The effect of idebenone, a coenzyme Q analogue, on hydrophobic bile acid toxicity to isolated rat … Idebenone treatment in Friedreich patients: one-year-long randomized placebo-controlled trial Levodopa The response to levodopa in Parkinson's disease: imposing pharmacological law and order Minaprine Double-blind, placebo-controlled, fixed dose trial of minaprine in patients with major depression. Minaprine, a new drug with antidepressant properties. Oxiracetam Oxiracetam prevents the hippocampal cholinergic hypofunction induced by the NMDA receptor blocker … Interactions between oxiracetam, aniracetam and scopolamine on behavior and brain acetylcholine … of hippocampally-mediated learning and protein kinase C activity by oxiracetam in learning-impaired … Clinical studies with oxiracetam in patients with dementia of Alzheimer type and multi-infarct … Oxiracetam in dementia: a double-blind, placebo-controlled study Oxiracetam prevents the MK-801 induced amnesia for the elevated plus-maze in mice Oxiracetam in the treatment of primary degenerative and multi-infarct dementia: a double-blind, … Oxiracetam increases the release of endogenous glutamate from depolarized rat hippocampal slices Oxiracetam and aniracetam increase acetylcholine release from the rat hippocampus in vivo Selegiline versus oxiracetam in patients with Alzheimer-type dementia Phenylethylamine (PEA) Phosphatidylserine Phosphatidylserine
specific binding protein in rat brain: purification and characterization Piracetam Smart Drugs: Enhancing Cognitive Function with Piracetam Piracetam
improves activated blood flow and facilitates rehabilitation of poststroke
aphasic patients. Piracetam
relieves symptoms in progressive myoclonus epilepsy: a multicentre,
randomised, double blind, crossover study comparing the efficacy and
safety of three dosages of oral piracetam with placebo Modulating
effect of the nootropic drug, piracetam on stress- and subsequent
morphine-induced prolactin secretion in male rats Design
and Study of Piracetam-like Nootropics, Controversial Members of the
Problematic Class of Cognition-Enhancing Drugs Pyritinol Neurochemical studies on the mechanism of action of pyritinol. On the effects of pyritinol on functional deficits of patients with organic mental disorders. Activation PET as an instrument to determine therapeutic efficacy in Alzheimer's disease Protection of cell proteins against free-radical attack by nootropic drugs: scavenger effect of pyritinol confirmed by electron spin resonance spectroscopy. Neurochemical effects of pyritinol and their relevance for the treatment of brain function deficits in old age Pyritinol hydrochloride and cognitive functions: influence on children in slow learner classes Efficacy of pyritinol versus hydergine upon cognitive performance in patients with senile dementia of the Alzheimer's type: A double-blind multi-center trial Vinpocetine Vinpocetine
for cognitive impairment and dementia 1. University of California at San Diego San Diego, CA "Introduction to the Human Brain" with Carl Sagan "Discussing Brain and Memory" with Eric Kandel (Columbia) "Consciousness, Qualia, and Self" with V.S. Ramachandran (UCSD) "Philosophy in the Age of Neuroscience" with Patricia Churchland (UCSD) "Patricia Churchland on Neurophilosophy" with Bill Moyers
"Brain Development" with Joan Stiles (UCSD) "The Origin of the Human Mind: Brain Imaging and Evolution" with Martin Sereno (UCSD) "Neuroscience and Society" with Martha Farah (UPenn) "Pharmacological Enhancements" with Anjan Chatterjee (UPenn) "Transhumanism and Cognitive Enhancement" with Susan Schneider (UPenn) Cerebral Health Home l Center for Neurobiological
Science [C.N.S.] l Brain Health Blog l Cognitive Enhancers
Cerebral Health Home - Center for Neurobiological
Science [C.N.S.] - Brain Health Blog - Cognitive Enhancers
support brain research
please notify synapse@cerebralhealth.com if
a link is broken or for url recommendations
video presentation- October, 2004
by Paul M. Coates, PhD, Office
of Dietary Supplements, National
Institutes of Health
by Ray Sahelian, M.D.
Nutrition Research Newsletter, May 2003
The University of Pittsburgh School of Medicine
by John D Fernstrom
Harvard Medical School and Harvard School of Public Health
by Francine Grodstein, Jennifer Chen and Walter C Willett
Duke University Medical Center, March 2004
by Doug Phillips
by Scott Rifkin
by Ronald Bailey
by Jay Ingram
by David Tuller
LE Magazine May 2000
by Ivy Greenwell
by Eugene Russo
The Economist, Sept. 16, 2004
by Eugene Russo
by Rita Rubin, USA TODAY
by Nadia Halim
Parnetti L, Senin U, Mecocci P.
Perugia University, Italy. parnetti@unipg.it
Hayes C.E.
Proceedings of the Nutrition Society, Volume 59, Number 4, November 2000 , pp. 531-535(5)
A. Payne
Department of Nutrition & Dietetics, Liberton Hospital, Lasswade Road, Edinburgh, UK
Gerard E. Hogarty, MSW; Samuel Flesher, PhD; Richard Ulrich, MS; Mary Carter, PhD; Deborah Greenwald, PhD; Michael Pogue-Geile, PhD; Matcheri Kechavan, MD; Susan Cooley, MSN; Ann Louise DiBarry, MSN; Ann Garrett, PhD; Haranath Parepally, MD; Rebecca Zoretich, MSEd
Arch Gen Psychiatry. 2004;61:866-876.
Hudson S, Tabet N.
Psychiatry, Maudsley Hospital, Maudsley Hospital, London, UK
Thal LJ, Calvani M, Amato A, Carta A.
Department of Neurosciences, University of California-San Diego School
of Medicine, La Jolla, CA 92093-0624, USA. lthal@ucsd.edu
Hagen TM, Liu J, Lykkesfeldt J, Wehr CM, Ingersoll RT, Vinarsky V,
Bartholomew JC, Ames BN.
Department of Biochemistry and Biophysics, Linus Pauling Institute,
Oregon State University, Corvallis, OR 97331, USA.
Tomassini V, Pozzilli C, Onesti E, Pasqualetti P, Marinelli F, Pisani
A, Fieschi C.
Department of Neurological Sciences, University of Rome "La Sapienza",
viale dell' Universita 30, Rome 00185, Italy.
Bianchetti A., Rozzini R., Trabucchi M.
Geriatric Research Group, Brescia, Italy
L Lucchi, A Pascale, F Battaini, S Govoni, M … - Life Sci, 1993 - ncbi.nlm.nih.gov
L Parnetti, G Abate, L Bartorelli, D Cucinotta, M … - Drugs Aging, 1993 - ncbi.nlm.nih.gov
C Lacomba, R Cagiano, O Maci, J Valerio, V Cuomo - Drug Development Research, 1992 - doi.wiley.com
G Aleppo, F Nicoletti, MA Sortino, G Casabona, U … - Pharmacology and Toxicology, 1994 - grande.nal.usda.gov
G Barbagallo Sangiorgi, M Barbagallo, M Giordano, … - Annals of the New York Academy of Sciences, 1994 - annalsonline.org
Douglas S.F. Ling and Larry S. Benardo
Department of Physiology and Pharmacology, State University of New
York Downstate Medical Center, Brooklyn, NY 11203, USA
Department of Physiology and Pharmacology, State University of New
York Downstate Medical Center, Brooklyn, NY 11203, USA; Department
of Neurology, State University of New York Downstate Medical Center,
Brooklyn, NY 11203, USA
J. Josh Lawrence, Stephan Brenowitz, and Laurence O. Trussell
Oregon Hearing Research Center and Vollum Institute, Oregon Health
and Science University, Portland, Oregon
I Ito, S Tanabe, A Kohda and H Sugiyama
Fujigotemba Research Laboratories, Chugai Pharmaceutical Company, Gotemba, Japan.
Eve M. Taylor, Rongzi Yan, Nils Hauptmann, Timothy J. Maher, Daniela
Djahandideh and Alvin J. Glasky
NeoTherapeutics Inc., Irvine, California
Lakshmi-Chandra Mishra, MD (Ayur), PhD, Betsy B. Singh, PhD, Simon Dagenais, BA
Ziauddin M, Phansalkar N, Patki P, Diwanay S, Patwardhan B.
Medinova Diagnostics Center, Indian Drugs Research Association, Pune, India.
Neuroreport. 11(9):1981-1985, June 26, 2000.
Neuroreport. 13(14):1715-1720, October 7, 2002.
Bhalla P, Nehru B.
Department of Biophysics,Panjab University, Chandigarh 160 014, India. Exp Gerontol. 2005 Aug 30
Mirchev N.
Sharma D, Maurya AK, Singh R.
School of Life Sciences, Jawaharlal Nehru University, New Delhi, India.
Nandy K, Bourne GH.
Jan Krzysztof Blusztajn
Department of Pathology and Laboratory Medicine, Boston University School of Medicine
S H Zeisel, J K Blusztajn
Deapartment of Nutrition, School of Public Health and School of Medicine, University of North Carolina at Chapel Hill
Department of Pathology, Boston University School of Medicine
Steven H. Zeisel MD, PhD
Department of Nutrition, School of Public Health, School of Medicine, University of North Carolina, Chapel Hill, North Carolina, USA
S. H. Zeisel
Department of Nutrition, School of Public Health, University of North Carolina, Chapel Hill 27599
Steven H. Zeisel, MD, PhD
Department of Nutrition, School of Public Health, School of Medicine, University of North Carolina at Chapel Hill, North Carolina
Horrocks LA, Yeo YK
Docosa Foods Ltd, 1275 Kinnear Road, Columbus, OH, 43212-1155, USA
Birch EE, Hoffman DR, Uauy R, Birch DG, Prestidge C.
Retina Foundation of the Southwest, Dallas, Texas 75321, USA.
Ahmad A, Moriguchi T, Salem N.
Section of Nutritional Neuroscience, Laboratory of Membrane Biochemistry & Biophysics, Division of Intramural Clinical and Biological Research,
National Institutes on Alcohol Abuse and Alcoholism, National Institutes
of Health, Bethesda, MD, USA.
Martinez M, Vazquez E, Garcia-Silva MT, Manzanares J, Bertran JM,
Castello F, Mougan I.
Hospital Materno-Infantil Vall d'Hebron, Barcelona, Spain, and the
Hospital 12 de Octubre, Madrid, Spain. mmartinez@cinet.fcr.es
Winston W. K. Koo, MBBS, FACN
Departments of Pediatrics, Obstetrics and Gynecology, Wayne State
University, Detroit, Michigan
Gwendolyn Barceló-Coblijn, Endre Hgyes, Klára Kitajka,
László G. Puskás, Ágnes Zvara , László Hackler, Jr. , Csaba Nyakas , Zsuzsa Penke and Tibor Farkas
Institute of Biochemistry and Laboratory of Functional Genomics, Biological
Research Center, Hungarian Academy of Sciences, H-6726 Szeged, Hungary;
Neurophysiological Research Laboratory of Hungarian Academy of Sciences,
Semmelweis University, H-1085 Budapest, Hungary; and Department of
Comparative Physiology, University of Szeged, H-6726 Szeged, Hungary
Paul Root Wolpe
Department of Psychiatry, Department of Medical Ethics, Department
of Sociology, and Center for Bioethics, University of Pennsylvania,
Philadelphia, PA 19104, USA
M. Levenson, Ph.D. and J. David Sweatt, Ph.D.
Baylor College of Medicine Department of Neuroscience
GL Wenk - Psychopharmacology (I 989) - springerlink.com
... of action of cognitive enhancers ... These four lines of research have implications for
the role of glucose in the action of specific cognitive enhancers. ...
TW Robbins, G McAlonan, JL Muir, BJ Everitt - Behav Brain Res, 1997 - ingentaconnect.com
... Cognitive enhancers in theory and practice: studies of the cholinergic hypothesis
of cognitive deficits in Alzheimer's disease. Authors ...
P Chopin, M Briley - Psychopharmacology (Berl), 1992 - ncbi.nlm.nih.gov
Effects of four non-cholinergic cognitive enhancers in comparison with tacrine
and galanthamine on scopolamine-induced amnesia in rats. ...
H Tsukada, T Kakiuchi, I Ando, Y Ouchi - 1997 - jpet.aspetjournals.org
... Functional Activation of Cerebral Blood Flow Abolished by Scopolamine Is Reversed
by Cognitive Enhancers Associated with Cholinesterase Inhibition: A Positron ...
KJ Ressler, BO Rothbaum, L Tannenbaum, P Anderson, … - Arch Gen Psychiatry, 2004 - ncbi.nlm.nih.gov
Click here to read Cognitive enhancers as adjuncts to psychotherapy: use of
D-cycloserine in phobic individuals to facilitate extinction of fear. ...
S Kaneko, T Maeda, M Satoh - Behav. Brain Res, 1997 - ingentaconnect.com
... Cognitive enhancers and hippocampal long-term potentiation in vitro. Authors:
Kaneko S.; Maeda T.; Satoh M. 1. Source: Behavioural ...
G Lynch - Curr. Opin. Pharmacol, 2004 - ingentaconnect.com
... AMPA receptor modulators as cognitive enhancers. Author: Lynch G. Source: Current
Opinion in Pharmacology, February 2004, vol. 4, no. 1, pp. 4-11(8). ...
Y Nomura, Y Kitamura, T Ohnuki, T Arima, Y … - Behav. Brain Res, 1997 - ingentaconnect.com
... NMDA, benzodiazepine receptors and protein kinase C in the brain of the
senescence-accelerated mouse: an animal model useful for studies on cognitive enhancers. ...
R Scott, R Bourtchuladze, S Gossweiler, J Dubnau, … - J. Mol. Neurosci, 2002 - now.humanapress.com
Page 1. CREB and the Discovery of Cognitive Enhancers Roderick Scott, 1 Rusiko
Bourtchuladze, 1 Scott Gossweiler, 1 ... Page 3. CREB and Cognitive Enhancers 173 ...
JJ Lambrecht - Journal of Research on Computing in Education, 1993 - eric.ed.gov
Title: EJ469263 - Applications Software as Cognitive Enhancers. Abstract:
Discusses the use of microcomputer applications software ...
Solomon PR, Adams F, Silver A, Zimmer J, DeVeaux R.
Bronfman Science Center, Williams College, 33 Hoxsey St, Williamstown,
MA 01267, USA. psolomon@williams.edu
Ahlemeyer B, Krieglstein J.
Institut fur Pharmakologie und Toxikologie, Fachbereich Pharmazie
der Philipps-Universitat Marburg, Ketzerbach 63, 35032 Marburg, Germany.
Mia L. Raves, Michal Harel, Yuan-Ping Pang, Israel Silman, Alan P. Kozikowski & Joel L. Sussman
Xu SS, Gao ZX, Weng Z, Du ZM, Xu WA, Yang JS, Zhang ML, Tong ZH, Fang YS, Chai XS, et al.
Zhejiang Supervision and Detection Station of Drug Abuse, Zhejiang Medical University, Hangzhou, China.
Lack
of efficacy of hydergine in patients with Alzheimer's disease
TL Thompson, CM Filley, WD Mitchell, KM Culig, M LoVerde, and RL Byyny
Department of Psychiatry, University of Colorado School of Medicine,
Denver.
I Hindmarch, AC Parrott, and M Lanza
H Gutzmann, D Hadler - J. Neural Transm, 1998 - ncbi.nlm.nih.gov
Sustained efficacy and safety of idebenone in the treatment of Alzheimer's
disease: update on a 2-year double-blind multicentre study. ...
G Weyer, RM Babej-Dolle, D Hadler, S Hofmann, WM … - Neuropsychobiology, 1997 - ncbi.nlm.nih.gov
A controlled study of 2 doses of idebenone in the treatment of Alzheimer's disease. ...idebenone. PMID: 9267856 [PubMed - indexed for MEDLINE]
L Schols, M Vorgerd, M Schillings, G Skipka, J … - Neurosci Lett, 2001 - ingentaconnect.com
... Idebenone in patients with Friedreich ataxia. ... Idebenone, a free-radical scavenger, protects mitochondrial function in in vitro models of FA. ...
JC Gillis, P Benefield, D McTavish - 1994 - ncbi.nlm.nih.gov
Idebenone. A review ... Zealand. Idebenone is a benzoquinone compound which has been investigated in elderly patients with dementia. Its ...
KN Shivaram, BM Winklhofer-Roob, MS Straka, MW … - Free Radic Biol Med, 1998 - ncbi.nlm.nih.gov
... The effect of idebenone, a coenzyme Q analogue, on hydrophobic bile acid toxicity to isolated rat hepatocytes and hepatic mitochondria. ...
C Mariotti, A Solari, D Torta, L Marano, C … - Neurology, 2003 - neurology.org
... Idebenone treatment in Friedreich patients: One-year-long randomized placebo-controlled trial. ... Idebenone in patients with Friedreich ataxia. Neurosci Lett . ...
Nutt JG, Holford NH.
Department of Neurology, Oregon Health Sciences University, Portland 97201-3098, USA.
A.M. Gotham, R.G. Brown and C.D. Marsden
From the MRC Movement Disorders Research Group, University Department of Neurology and Parkinson s Disease Society Research Centre, Institute of Psychiatry, London
Amsterdam JD, Dunner DL, Fabre LF, Kiev A, Rush AJ, Goodman LI.
Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia
Biziere K, Worms P, Kan JP, Mandel P, Garattini S, Roncucci R.
P Belfiore, F Ponzio, R Biagetti, C Berettera, M … - Neuroscience Letters, 1992 - ncbi.nlm.nih.gov
Oxiracetam prevents the hippocampal cholinergic hypofunction induced by the
NMDA receptor blocker AP7. Belfiore P, Ponzio F, Biagetti ...
G Spignoli, G Pepeu - Pharmacol Biochem Behav, 1987 - ncbi.nlm.nih.gov
Interactions between oxiracetam, aniracetam and scopolamine on behavior and brain
acetylcholine. ... Lower and higher doses of oxiracetam were ineffective. ...
DE Fordyce, VJ Clark, R Paylor, JM Wehner - Brain Res, 1995 - ingentaconnect.com
... Enhancement of hippocampally-mediated learning and protein kinase C activity
by oxiracetam in learning-impaired DBA/2 mice. Authors ...
C Villardita, S Grioli, C Lomeo, C Cattaneo, J … - Neuropsychobiology, 1992 - ncbi.nlm.nih.gov
Clinical studies with oxiracetam in patients with dementia of Alzheimer
type and multi-infarct dementia of mild to moderate degree. ...
G Bottini, G Vallar, S Cappa, GC Monza, E Scarpini … - Acta Neurol Scand, 1992 - ncbi.nlm.nih.gov
Oxiracetam in dementia: a double-blind, placebo-controlled study. ... Pyrrolidines;
oxiracetam. PMID: 1414239 [PubMed - indexed for MEDLINE]
Z Hlinak, I Krejci - Behav Brain Res, 2000 - ingentaconnect.com
... Oxiracetam prevents the MK-801 induced amnesia for the elevated plus-maze
in mice. Authors: Hlinak Z. 1 ; Krejc I. Source: Behavioural ...
G Maina, L Fiori, R Torta, MB Fagiani, L Ravizza, … - Neuropsychobiology, 1989 - ncbi.nlm.nih.gov
Oxiracetam in the treatment of primary degenerative and multi-infarct
dementia: a double-blind, placebo-controlled study. Maina ...
M Marchi, E Besana, M Raiteri - Eur J Pharmacol, 1990 - ncbi.nlm.nih.gov
Oxiracetam increases the release of endogenous glutamate from depolarized rat
hippocampal slices. Marchi M, Besana E, Raiteri M. Istituto ...
MG Giovannini, P Rodino, D Mutolo, G Pepeu - Drug Development Research, 1993 - doi.wiley.com
... Research Article Oxiracetam and Aniracetam Increase Acetylcholine ... ABSTRACT The effect
of two nootropic drugs, oxiracetam and aniracetam, on cholinergic neu- ...
A Falsaperla, PAM Preti, C Oliani - Clin Ther, 1990 - ncbi.nlm.nih.gov
Selegiline versus oxiracetam in patients with Alzheimer-type dementia. Falsaperla
A, Monici Preti PA, Oliani C. Department of Neurology ...
EM Parker and LX Cubeddu
Department of Pharmacology, School of Medicine, University of North Carolina, Chapel Hill
T. Nakaoka, N. Kojima, T. Hamamoto, N. Kurosawa, Y. C. Lee, H. Kawasaki,
K. Suzuki and S. Tsuji
Glyco Molecular Biology, Frontier Research Program, Institute of Physical
and Chemical Research (RIKEN), Saitama.
Kessler J, Thiel A, Karbe H, Heiss WD.
Max-Planck-Institute for Neurological Research, Cologne, Germany. josef.kessler@pet.mpin-koeln.mpg.de
Long-term and high-dose piracetam treatment of Alzheimer's
disease
B Croisile, M Trillet, J Fondarai, B Laurent, F Mauguiere and M Billardon
Department of Neurology, Hopital Neurologique, Lyon, France.
Marjaleena Koskiniemi, Betty Van Vleymen, Lauri Hakamies, Salla Lamusuo,
Jaakko Taalase
Haartman Institute, Department of Virology, University of Helsinki,
Haartmaninkatu 3, SF-00290, Helsinki, Finland, UCB Pharma SA, Chemin
du Foriest, Braine-l'Alleud, B1420 Belgium, Central Hospital of Vaasa,
SF-65130 Vaasa, Finland, Department of Neurology, University Hospital
of Turku, SF-00290 Turku, Finland, Central Hospital of Mikkeli, SF-50100
Mikkeli, Finland
A Matton, S Engelborghs, F Bollengier, E Finne and L Vanhaeist
Dept. of Pharmacology, Faculty of Medicine, Vrije Universiteit Brussel,
Belgium.
Fulvio Gualtieri, Dina Manetti, Maria Novella Romanelli and Carla
Ghelardini
Dipartimento di Scienze Farmaceutiche, Universita' di Firenze, Via
G. Capponi 9, I-50121 Firenze, Italy
Dipartimento di Farmacologia Preclinica e Clinica, Universita' di
Firenze, Viale Pieraccini 6, I-50139 Firenze, Italy
Greiner HE, Haase AF, Seyfried CA.
Biological Research, Department of Neurochemistry, E. Merck, Darmstadt, FRG.
Herrmann WM, Kern U, Rohmel J.
W. D. Heiss, J. Kessler, I. Slansky, R. Mielke, B. Szelies and K. Herholz
Max-Planck-Institut fur Neurologische Forschung and Neurologische Universitatsklinik, Koln, Germany.
Pavlik A, Pilar J.
Institute of Physiology, Czechoslovak Academy of Sciences, Prague.
Dr. Christoph A. Seyfried
Department of Neurochemistry, Biological Research, E. Merck, Darmstadt, Federal Republic of Germany
U Walti, M Kuenzler, J Schild, F Vassella, E Pavlincova, J Bircher and N Herschkowitz
Alzheimer's Research (United Kingdom) , 1996, 2/3 (79-84)
Szatmari Sz, Whitehouse PJ
Cochrane Review
vote here
(rankings compiled by Doug Phillips, Director of R&D)
2.
3.
4.
5.
6.
7.
8.
9.
10.
